Active ingredientBremelanotideCat. No. P-B102-001CAS 189691-06-3Family · Pharmaceutical analytical standards
Bremelanotide
A peptide agonist of melanocortin receptors (mainly MC3 and MC4), approved in the United States in June 2019 for hypoactive sexual desire disorder in premenopausal women; it is given by subcutaneous injection. This family brings together the active ingredient.
Did you know?It is a small cyclic peptide of seven amino acids modelled on alpha-MSH, the hormone that stimulates melanin: it stems from University of Arizona research on analogues of this hormone, originally intended for sunless tanning.
Go to the active ingredient →Active ingredientBremelanotideCat. No. P-B102-001CAS 189691-06-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.